Breadcrumb
- Home
- Publications
- Proceedings
- 2025 AIChE Annual Meeting
- Separations Division
- Continuous Crystallization Processes
- (504c) Impact of Multiple Antisolvent Addition Points in a Tower Crystallizer
In this work, we present a continuous crystallization strategy of multiple points of antisolvent addition along the TWC. The process performance is evaluated based on critical quality attributes of the crystallized active pharmaceutical ingredient, e.g., crystal size distribution and morphology. The results are benchmarked against a traditional lab-scale MSMPRC setup of equivalent volume to elucidate the impact of the TWC configuration on crystallization behavior.
References
(1) Cote, A.; Erdemir, D.; Girard, K. P.; Green, D. A.; Lovette, M. A.; Sirota, E.; Nere, N. K. Perspectives on the Current State, Challenges, and Opportunities in Pharmaceutical Crystallization Process Development. Cryst. Growth Des. 2020, 20, 7568–7581. DOI:10.1021/acs.cgd.0c00847.
(2) Aprile, G.; Pandit, A. V.; Albertazzi, J.; Vetter, T.; Viano, R.; Milani, L.; Adamo, A.; Myerson, A. S.; Stelzer, T. Residence Time Distribution Characterization and Proof-of-Concept of a Novel Stacked 7-Stage Continuous Crystallizer Cascade with Diaphragm-Driven Slurry Transfer. Ind. Eng. Chem. Res. 2024. DOI:10.1021/acs.iecr.4c02153.